Clinical Trial Update: 24-Hour Intraocular Pressure Control With Bimatoprost/Timolol Versus Latanoprost as First Choice [Phase 4]

View source ↗

Summary

This Phase 4 trial compares 24-hour intraocular pressure control with fixed-dose bimatoprost/timolol versus latanoprost as initial therapy for glaucoma; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Ganfort (bimatoprost; timolol)
• Xalatan (latanoprost)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Glaucoma | Phase 4 | Status: COMPLETED